STRIDES PHARMA SCIENCE
|
STRIDES PHARMA SCIENCE Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹92 Cr | ₹92 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr |
| Equity - Authorised | ₹218 Cr | ₹188 Cr | ₹188 Cr | ₹188 Cr | ₹188 Cr |
| Equity - Issued | ₹92 Cr | ₹92 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr |
| Equity Paid Up | ₹92 Cr | ₹92 Cr | ₹90 Cr | ₹90 Cr | ₹90 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹0.51 Cr | ₹3.09 Cr | ₹19 Cr | ₹2.45 Cr | ₹4.72 Cr |
| Total Reserves | ₹2,459 Cr | ₹2,031 Cr | ₹2,103 Cr | ₹2,267 Cr | ₹2,682 Cr |
| Securities Premium | ₹1,509 Cr | ₹1,823 Cr | ₹1,754 Cr | ₹1,732 Cr | ₹1,727 Cr |
| Capital Reserves | ₹-115 Cr | ₹33 Cr | ₹36 Cr | ₹34 Cr | ₹21 Cr |
| Profit & Loss Account Balance | ₹459 Cr | ₹-284 Cr | ₹-200 Cr | ₹2.31 Cr | ₹485 Cr |
| General Reserves | ₹404 Cr | ₹404 Cr | ₹404 Cr | ₹404 Cr | ₹402 Cr |
| Other Reserves | ₹202 Cr | ₹55 Cr | ₹109 Cr | ₹95 Cr | ₹47 Cr |
| Reserve excluding Revaluation Reserve | ₹2,459 Cr | ₹2,031 Cr | ₹2,103 Cr | ₹2,267 Cr | ₹2,682 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹2,552 Cr | ₹2,126 Cr | ₹2,212 Cr | ₹2,359 Cr | ₹2,777 Cr |
| Minority Interest | ₹35 Cr | ₹-54 Cr | ₹-39 Cr | ₹24 Cr | ₹37 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹558 Cr | ₹618 Cr | ₹1,041 Cr | ₹745 Cr | ₹873 Cr |
| Non Convertible Debentures | - | ₹123 Cr | ₹121 Cr | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹646 Cr | ₹661 Cr | ₹1,042 Cr | ₹1,117 Cr | ₹978 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹-88 Cr | ₹-165 Cr | ₹-122 Cr | ₹-372 Cr | ₹-104 Cr |
| Unsecured Loans | ₹13 Cr | ₹53 Cr | ₹99 Cr | ₹91 Cr | ₹9.15 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | ₹3.88 Cr |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | ₹13 Cr | ₹57 Cr | ₹102 Cr | ₹94 Cr | ₹5.30 Cr |
| Other Unsecured Loan | ₹-0.06 Cr | ₹-3.83 Cr | ₹-3.04 Cr | ₹-3.59 Cr | ₹-0.03 Cr |
| Deferred Tax Assets / Liabilities | ₹-150 Cr | ₹-227 Cr | ₹-220 Cr | ₹-179 Cr | ₹-152 Cr |
| Deferred Tax Assets | ₹266 Cr | ₹270 Cr | ₹326 Cr | ₹295 Cr | ₹262 Cr |
| Deferred Tax Liability | ₹117 Cr | ₹43 Cr | ₹106 Cr | ₹116 Cr | ₹110 Cr |
| Other Long Term Liabilities | ₹66 Cr | ₹85 Cr | ₹218 Cr | ₹245 Cr | ₹287 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹114 Cr | ₹92 Cr | ₹73 Cr | ₹64 Cr | ₹246 Cr |
| Total Non-Current Liabilities | ₹602 Cr | ₹621 Cr | ₹1,210 Cr | ₹966 Cr | ₹1,264 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹1,032 Cr | ₹852 Cr | ₹982 Cr | ₹1,072 Cr | ₹1,134 Cr |
| Sundry Creditors | ₹1,032 Cr | ₹852 Cr | ₹982 Cr | ₹1,072 Cr | ₹1,134 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹307 Cr | ₹342 Cr | ₹528 Cr | ₹697 Cr | ₹421 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹30 Cr | ₹26 Cr | ₹32 Cr | ₹28 Cr | ₹29 Cr |
| Interest Accrued But Not Due | ₹7.48 Cr | ₹11 Cr | ₹16 Cr | ₹5.81 Cr | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | ₹50 Cr | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹270 Cr | ₹255 Cr | ₹480 Cr | ₹663 Cr | ₹392 Cr |
| Short Term Borrowings | ₹1,136 Cr | ₹1,574 Cr | ₹1,331 Cr | ₹1,497 Cr | ₹1,024 Cr |
| Secured ST Loans repayable on Demands | ₹1,004 Cr | ₹1,468 Cr | ₹1,227 Cr | ₹1,364 Cr | ₹962 Cr |
| Working Capital Loans- Sec | ₹897 Cr | ₹1,247 Cr | ₹956 Cr | ₹1,013 Cr | ₹681 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-765 Cr | ₹-1,142 Cr | ₹-851 Cr | ₹-881 Cr | ₹-619 Cr |
| Short Term Provisions | ₹115 Cr | ₹112 Cr | ₹149 Cr | ₹146 Cr | ₹159 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹34 Cr | ₹40 Cr | ₹27 Cr | ₹24 Cr | ₹35 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹81 Cr | ₹72 Cr | ₹122 Cr | ₹123 Cr | ₹124 Cr |
| Total Current Liabilities | ₹2,592 Cr | ₹2,879 Cr | ₹2,990 Cr | ₹3,412 Cr | ₹2,738 Cr |
| Total Liabilities | ₹5,780 Cr | ₹5,572 Cr | ₹6,373 Cr | ₹6,761 Cr | ₹6,817 Cr |
| ASSETS | |||||
| Gross Block | ₹2,897 Cr | ₹2,873 Cr | ₹3,325 Cr | ₹3,232 Cr | ₹2,841 Cr |
| Less: Accumulated Depreciation | ₹1,009 Cr | ₹1,020 Cr | ₹1,026 Cr | ₹898 Cr | ₹690 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹1,888 Cr | ₹1,853 Cr | ₹2,298 Cr | ₹2,333 Cr | ₹2,151 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹100 Cr | ₹80 Cr | ₹48 Cr | ₹56 Cr | ₹228 Cr |
| Non Current Investments | ₹340 Cr | ₹197 Cr | ₹439 Cr | ₹540 Cr | ₹598 Cr |
| Long Term Investment | ₹340 Cr | ₹197 Cr | ₹439 Cr | ₹540 Cr | ₹598 Cr |
| Quoted | ₹323 Cr | ₹1.11 Cr | ₹2.08 Cr | ₹4.78 Cr | ₹14 Cr |
| Unquoted | ₹25 Cr | ₹204 Cr | ₹445 Cr | ₹544 Cr | ₹592 Cr |
| Long Term Loans & Advances | ₹140 Cr | ₹256 Cr | ₹217 Cr | ₹211 Cr | ₹188 Cr |
| Other Non Current Assets | ₹95 Cr | ₹123 Cr | ₹12 Cr | ₹10 Cr | ₹547 Cr |
| Total Non-Current Assets | ₹2,681 Cr | ₹2,603 Cr | ₹3,130 Cr | ₹3,399 Cr | ₹4,000 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹70 Cr | ₹106 Cr | ₹51 Cr | - | ₹99 Cr |
| Quoted | ₹70 Cr | ₹106 Cr | ₹51 Cr | - | - |
| Unquoted | - | - | - | - | ₹99 Cr |
| Inventories | ₹1,278 Cr | ₹1,126 Cr | ₹1,147 Cr | ₹1,174 Cr | ₹1,201 Cr |
| Raw Materials | ₹436 Cr | ₹507 Cr | ₹522 Cr | ₹575 Cr | ₹552 Cr |
| Work-in Progress | ₹52 Cr | ₹48 Cr | ₹51 Cr | ₹48 Cr | ₹39 Cr |
| Finished Goods | ₹366 Cr | ₹439 Cr | ₹462 Cr | ₹278 Cr | ₹536 Cr |
| Packing Materials | - | - | - | - | - |
| Stores  and Spare | ₹40 Cr | ₹34 Cr | ₹27 Cr | ₹23 Cr | ₹22 Cr |
| Other Inventory | ₹383 Cr | ₹98 Cr | ₹86 Cr | ₹250 Cr | ₹52 Cr |
| Sundry Debtors | ₹1,203 Cr | ₹1,142 Cr | ₹1,299 Cr | ₹1,207 Cr | ₹1,111 Cr |
| Debtors more than Six months | ₹65 Cr | ₹165 Cr | ₹125 Cr | ₹240 Cr | ₹95 Cr |
| Debtors Others | ₹1,179 Cr | ₹1,027 Cr | ₹1,219 Cr | ₹1,010 Cr | ₹1,077 Cr |
| Cash and Bank | ₹137 Cr | ₹191 Cr | ₹316 Cr | ₹187 Cr | ₹180 Cr |
| Cash in hand | ₹0.27 Cr | ₹0.19 Cr | ₹0.27 Cr | ₹0.27 Cr | ₹0.30 Cr |
| Balances at Bank | ₹121 Cr | ₹163 Cr | ₹261 Cr | ₹175 Cr | ₹160 Cr |
| Other cash and bank balances | ₹15 Cr | ₹28 Cr | ₹55 Cr | ₹12 Cr | ₹19 Cr |
| Other Current Assets | ₹276 Cr | ₹229 Cr | ₹169 Cr | ₹648 Cr | ₹98 Cr |
| Interest accrued on Investments | ₹0.24 Cr | ₹0.14 Cr | ₹1.33 Cr | ₹0.12 Cr | ₹3.98 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | ₹9.81 Cr | ₹0.82 Cr | ₹0.55 Cr | ₹1.42 Cr |
| Prepaid Expenses | ₹62 Cr | ₹71 Cr | ₹64 Cr | ₹54 Cr | ₹53 Cr |
| Other current_assets | ₹214 Cr | ₹148 Cr | ₹103 Cr | ₹593 Cr | ₹40 Cr |
| Short Term Loans and Advances | ₹136 Cr | ₹175 Cr | ₹153 Cr | ₹145 Cr | ₹129 Cr |
| Advances recoverable in cash or in kind | ₹32 Cr | ₹65 Cr | ₹57 Cr | ₹57 Cr | ₹34 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹103 Cr | ₹110 Cr | ₹97 Cr | ₹88 Cr | ₹95 Cr |
| Total Current Assets | ₹3,099 Cr | ₹2,969 Cr | ₹3,135 Cr | ₹3,362 Cr | ₹2,817 Cr |
| Net Current Assets (Including Current Investments) | ₹507 Cr | ₹90 Cr | ₹145 Cr | ₹-50 Cr | ₹79 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹5,780 Cr | ₹5,572 Cr | ₹6,373 Cr | ₹6,761 Cr | ₹6,817 Cr |
| Contingent Liabilities | ₹98 Cr | ₹475 Cr | ₹632 Cr | ₹834 Cr | ₹844 Cr |
| Total Debt | ₹1,796 Cr | ₹2,415 Cr | ₹2,774 Cr | ₹2,792 Cr | ₹2,103 Cr |
| Book Value | 276.83 | 230.95 | 242.83 | 262.48 | 309.09 |
| Adjusted Book Value | 276.83 | 230.95 | 242.83 | 262.48 | 309.09 |
Compare Balance Sheet of peers of STRIDES PHARMA SCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| STRIDES PHARMA SCIENCE | ₹8,101.2 Cr | -3.6% | -8.5% | -44.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.2% | 7.1% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | 0.8% | -6% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 1.2% | 6.4% | 13.1% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.2% | 1.4% | -0.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.2% | 5.8% | 4.2% | Stock Analytics | |
STRIDES PHARMA SCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| STRIDES PHARMA SCIENCE | -3.6% |
-8.5% |
-44.5% |
| SENSEX | 0% |
2.7% |
6.8% |
You may also like the below Video Courses